Meridian Wealth Management »

Neumora Therapeutics shares owned by Meridian Wealth Management

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Meridian Wealth Management from 13F filings

Historical chart of Meridian Wealth Management investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Meridian Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Meridian Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $108k 59k 1.82

More positions owned by Meridian Wealth Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Robinhood Mkts Com Cl A (HOOD)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Meridian Wealth Management

Top funds holding Neumora Therapeutics

Softbank Group Corp
MIC Capital Management UK
Siren
Vanguard Group
FMR
Wellcome Trust Limited, as Trustee of the Wellcome Trust
ICONIQ Capital
Lunate Capital
Millennium Management
T. Rowe Price Investment Management
Johnson & Johnson
BlackRock
Tang Capital Management
Renaissance Technologies
Two Sigma Advisers

View all funds holding Neumora Therapeutics